CCR1 antagonist 2(1202400-18-7)
- Name: CCR1 antagonist 2
- Synonyms:Urea, N-[(1R)-1-[[(4S)-4-(4-chlorophenyl)-4-hydroxy-3,3-dimethyl-1-piperidinyl]carbonyl]-2-methylpropyl]-N'-(2-hydroxy-2-methylpropyl)-;
- Molecular Formula:
- Molecular Weight:454.01
- CAS Registry Number:1202400-18-7
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1202400-18-7 CCR1 antagonist 2
Assay:99% Package:According to customer requirements Transportation:By Sea/Air/Courier Application:medicine
Min. Order:10Gram
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.1202400-18-7 CCR1 antagonist 2
Assay: 98%Min Appearance:Detailed in specifications Package:According to customer Storage:Store in dry, dark and ventilated place Transportation:By air or by sea Application:An important raw material and intermediate used in organic Synthesis, Pharmaceuticals
Min. Order:1Kilogram
Supplier:TAIZHOU ZHENYU BIOTECHNOLOGY CO., LTD [
China (Mainland)] CAS No.1202400-18-7 CCR1 antagonist 2
Assay:98%min Appearance:Off-white to light yellow powder Package:According to the clients requirement. Storage:Keep in cool place. Application:Pharmaceutical intermediates
Min. Order:0
Supplier:Hangzhou J&H Chemical Co., Ltd. [
China (Mainland)]
Other Product
- 865479-71-6/5-R-Rivaroxaban
- 565434-85-7/CBP-501
- 620616-08-2/Benzeneethanol, β-aMino-3-chloro-, hydrochloride (1:1), (βS)-
- 1229224-94-5/(αR)-α-Methyl-N-[3-[3-(trifluoroMethyl)phenyl)propyl]-1-napthaleneMethanaMine-N-oxide
- 496868-77-0/(2E)-3-(4'-Hydroxy-3'-tricyclo[3.3.1.13,7]dec-1-yl[1,1'-biphenyl]-4-yl)-2-propenoic acid
- 554435-83-5/Exjade Fe3+ chelate
- 1204416-97-6/TMC-647055
- 159878-04-3/[3S-(3S,4aS,8aS,2’R,3’R)]-2-[3’-N-CBz-amino-2’-hydroxy-4’-(phenyl)thio]butyldecahydroisoquinoline-3-N-t-butylcarboxamide
- 220662-95-3/RJR-2403 (oxalate)
- 864668-87-1/ENMD-119
- 1011557-82-6/Tenovin-6
- 557766-14-0/Benzo[3,4]-18-norandrosta-3,5-diene-3(2'H)-carboxylic acid, 3',4',5',6'-tetrahydro-17-(hydroxyimino)-4',4',9,14-tetramethyl-, methyl ester, (3β,4β,8α,9β,10α,13α,14β)- (9CI)
- 1233145-49-7/1-Piperidineacetamide, 4-[3-methoxy-4-[[7-(2-methoxyphenyl)pyrrolo[2,1-f][1,2,4]triazin-2-yl]amino]phenyl]-
- 869811-23-4/FLUORAPACIN
- 328232-95-7/Spiro[cyclohexane-1,3'(1'H)-furo[3,4-c]pyridine]-4-carboxamide, N-[1-(2-fluorophenyl)-1H-pyrazol-3-yl]-1'-oxo-, trans-
- 827034-92-4/D-erythro-Pentonic acid, 5-[[(1S)-2-[4-(2-butyn-1-yloxy)phenyl]-1-carboxyethyl]aMino]-3-C-carboxy-2,4,5-trideoxy-5-C-oxo-4-[(1E)-9-oxo-1-hexadecen-1-yl]-
- 174230-05-8/2-(6-Amino-4,5-dibromo-3-imino-3H-xanthen-9-yl)benzoic acid methyl ester hydrochloride
- 1001667-23-7/ACH 0141625
- 863971-19-1/SGD 1269
- 1202400-18-7/CCR1 antagonist 2
- 55665-79-7/4-Methyl-3-hexenoic acid
- 150556-72-2/2,4-Thiazolidinedione, 5-[(4-hydroxyphenyl)methyl]-3-(triphenylmethyl)-
- 92577-65-6/CarbaMic acid, N-[(propylaMino)sulfonyl]-, phenylMethyl ester
- 290815-30-4/N-(6-chloro-5-(2-Methoxyphenoxy)-2-(pyridin-4-yl)pyriMidin-4-yl)-5-Methylpyridine-2-sulfonaMide
- 184644-72-2/Methyl 3-(N-(4-chloro-3-Methylisoxazol-5-yl)sulfaMoyl)thiophene-2-carboxylate
- 57005-61-5/5-Methyl-6-oxo-1,6-dihydropyrazine-2,3-dicarbonitrile
- 848768-06-9/(R)-3-(2-(benzyloxy)-5-Methylphenyl)-N,N-diisopropyl-3-phenylpropan-1-aMine
- 406212-99-5/3-[2-Amino-6-[2-(cyclopropylmethoxy)-6-[(4-methoxyphenyl)methoxy]phenyl]-3-(hydroxymethyl)-4-pyridinyl]-1-piperidinecarboxylic acid tert-butyl ester
- 638217-07-9/6-Methoxy-N,2-diMethylbenzofuran-3-carboxaMide
- 98879-99-3/2(3H)-Benzofuranone, 6-methoxy-